Two Sigma Securities, LLC Adma Biologics, Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $16,749 - $22,252	4,827 Added 36.38%	18,097 $64,000
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $41,402 - $55,999	13,270 New	13,270 $48,000
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $167,651 - $263,355	-67,875 Reduced 77.74%	19,440 $75,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $177,249 - $249,720	87,315 New	87,315 $212,000
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $15,993 - $24,604	-11,184 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $13,209 - $18,885	-10,320 Reduced 47.99%	11,184 $20,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $23,439 - $35,696	21,504 New	21,504 $30,000

326

190M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.31B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.